These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3365281)

  • 21. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time-controlled release pseudoephedrine tablets: bioavailability and in vitro/in vivo correlations.
    Halsas M; Penttinen T; Veski P; Jürjenson H; Marvola M
    Pharmazie; 2001 Sep; 56(9):718-23. PubMed ID: 11593992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galenical development of a new sustained-release theophylline pellet formulation for once-daily administration.
    Benedikt G; Steinijans VW; Dietrich R
    Arzneimittelforschung; 1988 Aug; 38(8A):1203-9. PubMed ID: 3190808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo evaluation of tegaserod maleate pH-dependent tablets.
    Zhang SQ; Thumma S; Chen GH; Deng WB; Repka MA; Li SM
    Eur J Pharm Biopharm; 2008 May; 69(1):247-54. PubMed ID: 18037278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term therapy over 2 years with ambroxol (Mucosolvan) retard capsules in patients with chronic bronchitis. Results of a double-blind study of 180 patients].
    Cegla UH
    Prax Klin Pneumol; 1988 Sep; 42(9):715-21. PubMed ID: 3141915
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PH-dependent drug release from certain commercial tablets.
    Sutton JE; Lach JL; Wagner RS
    Am J Hosp Pharm; 1977 Dec; 34(12):1323-6. PubMed ID: 23005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh.
    Abdullah MD; Bepary S; Rouf AS
    Pak J Pharm Sci; 2008 Jan; 21(1):70-7. PubMed ID: 18166523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation.
    Chavanpatil M; Jain P; Chaudhari S; Shear R; Vavia P
    Int J Pharm; 2005 Nov; 304(1-2):178-84. PubMed ID: 16198522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo evaluation of ofloxacin sustained release pellets.
    Cui Y; Zhang Y; Tang X
    Int J Pharm; 2008 Aug; 360(1-2):47-52. PubMed ID: 18538518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride.
    Moursy NM; Afifi NN; Ghorab DM; El-Saharty Y
    Pharmazie; 2003 Jan; 58(1):38-43. PubMed ID: 12622251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Optimization of a floating osmotic pump system of ambroxol hydrochloride using central composite design-response surface methodology and its pharmacokinetics in Beagle dogs].
    Zhao F; Ma YL; Jin XL; Wang J; Cao DY
    Yao Xue Xue Bao; 2011 Dec; 46(12):1507-14. PubMed ID: 22375427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of taste masking agents on in situ gelling pectin formulations for oral sustained delivery of paracetamol and ambroxol.
    Miyazaki S; Kubo W; Itoh K; Konno Y; Fujiwara M; Dairaku M; Togashi M; Mikami R; Attwood D
    Int J Pharm; 2005 Jun; 297(1-2):38-49. PubMed ID: 15907595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a continuous fluid exchange system in the USP basket-stirrer dissolution test assembly. Part 11: Characterization of the dissolution profile of quinidine sustained-release dosage forms.
    Huynh-Ngoc T; Sirois Gérard
    J Pharm Belg; 1977; 32(1):67-75. PubMed ID: 16996
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.
    Miller DA; Gamba M; Sauer D; Purvis TP; Clemens NT; Williams RO
    Int J Pharm; 2007 Feb; 330(1-2):61-72. PubMed ID: 17034967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a dissolution test for a once-a-day combination tablet of immediate-release cetirizine dihydrochloride and extended-release pseudoephedrine hydrochloride.
    Likar MD; Mansour HL; Harwood JW
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):543-51. PubMed ID: 15975755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine.
    Lee KR; Kim EJ; Seo SW; Choi HK
    Arch Pharm Res; 2008 Aug; 31(8):1023-8. PubMed ID: 18787792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.